Rybelsus is semaglutide in a tablet, approved for type 2 diabetes. It went on sale in September 2019 at 3, 7 and 14 mg, and for six years it was the only semaglutide anyone could swallow.
That is no longer true, and almost nothing written about Rybelsus has caught up.
There are three semaglutide pills now
From the FDA's own National Drug Code directory:1
| Pill | Strengths | On sale since | Approved for |
|---|---|---|---|
| Rybelsus | 3, 7, 14 mg | September 2019 | Type 2 diabetes |
| Wegovy pill | 1.5, 4, 9, 25 mg | January 2026 | Obesity |
| Ozempic pill | 1.5, 4, 9 mg | April 2026 | Type 2 diabetes |
Note the strengths do not overlap. These are not three labels on one product: they are different formulations at different doses. A page telling you "the semaglutide pill" without saying which one is describing a market that ended in April.
Rybelsus is still listed in the FDA directory with no end date, so it has not been withdrawn. It simply is not alone any more.
The catch if you are paying cash
NovoCare Pharmacy is Novo Nordisk's own self-pay counter. It lists the Wegovy pill and the Ozempic pill, with published prices:2
Patients pay $149 for each month of 1.5 mg, $199 per month for 4 mg and $299 per month for 9 mg and 25 mg. One month defined as 1 bottle of 30 tablets.
NovoCare Pharmacy
It does not list Rybelsus.
We are not going to tell you why, because we do not know and speculating would be worse than saying so. What it means practically is that if you are paying out of pocket and looking for a published cash price on Rybelsus specifically, Novo's own pharmacy is not where you will find one.
What that leaves you asking
Two different questions depending on how you are paying.
If you have insurance and a Rybelsus prescription, none of the above necessarily matters. Your copay is set by your plan's formulary, not by Novo's cash counter, and Rybelsus is a long-established drug with a savings programme. What your insurer publishes is the useful thing to read.
If you are paying cash, the useful question is not what Rybelsus costs but which oral semaglutide you can actually buy and at what price. That is answerable:
Rybelsus against the injections
Worth being clear about, because people arrive at Rybelsus assuming a pill must be the cheap option or the weak one.
It is a daily tablet rather than a weekly injection, which some people strongly prefer and which is a legitimate reason to choose it. It is approved for blood sugar rather than weight, so if weight is the goal you are asking an off-label question, and the drug approved for that in tablet form is the Wegovy pill.
The honest summary
Rybelsus is a real, long-approved, still-marketed oral semaglutide for type 2 diabetes. It is now one of three, the other two arrived this year at different strengths, and Novo's own cash pharmacy carries the other two and not this one. If you have coverage, that is mostly trivia. If you are paying cash, it is the whole picture.